Abstract
Covert Hepatic Encephalopathy (CHE), previously known as Minimal Hepatic Encephalopathy, is a subtle cognitive defect found in 30–70 % of cirrhosis patients. It has been linked to poor quality of life, impaired fitness to drive, and increased mortality: treatment is possible. Despite its clinical significance, diagnosis relies on psychometric tests that have proved unsuitable for use in a clinical setting. We investigated whether measurement of saccadic latency distributions might be a viable alternative. We collected data on 35 cirrhosis patients at Addenbrooke’s Hospital, Cambridge, with no evidence of clinically overt encephalopathy, and 36 age-matched healthy controls. Performance on standard psychometric tests was evaluated to determine those patients with CHE as defined by the World Congress of Gastroenterology. We then compared visually-evoked saccades between those with CHE and those without, as well as reviewing blood test results and correlating saccadic latencies with biochemical parameters and prognostic scores. Cirrhosis patients have significantly longer median saccadic latencies than healthy controls. Those with CHE had significantly prolonged saccadic latencies when compared with those without CHE. Analysis of a cirrhosis patient’s saccades can diagnose CHE with a sensitivity of 75 % and a specificity of 75 %. We concluded that analysis of a cirrhosis patient’s saccadic latency distributions is a fast and objective measure that can be used as a diagnostic tool for CHE. This improved early diagnosis could direct avoidance of high-risk activities such as driving, and better inform treatment strategies.
Similar content being viewed by others
References
Ali FR, Michell AW, Barker RA, Carpenter RHS (2006) The use of quantitative oculometry in the assessment of Huntington’s disease. Exp Brain Res 169:237–245
Amodio P, Montagnese S, Gatta A, Morgan MY (2004) Characteristics of minimal hepatic encephalopathy. Metab Brain Dis 19:253–267
Antoniades CA, Altham PME, Mason SL, Barker RA, Carpenter RHS (2007) Saccadometry: a new tool for evaluating pre-symptomatic Huntington patients. Neuroreport 18:1133–1136
Antoniades CA, Zheyu X, Mason SL, Carpenter RHS, Barker RA (2010) Huntington’s disease: changes in saccades and hand-tapping over three years. J Neurol 257:1890–1898
Bajaj JS (2007) Testing for minimal hepatic encephalopathy in the United States: an AASLD survey. Hepatology 45:833–834
Bajaj JS, Hafeezullah M, Hoffmann RG, Saeian K (2007) Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. J Gastroenterol 102:1903–1909
Bajaj JS, Cordoba J, Mullen KD, Amodio P, Shawcross DL, Butterworth RF, Morgan MY, International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) (2011) The design of clinical trials in hepatic encephalopathy–an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement. Aliment Pharmacol Ther 33:739–747
Blei AT, Cordoba J, Gastroenterology TPPCotACo (2001) Hepatic encephalopathy. Am J Gastroenterol 96:1968–1976
Burrell JR, Hornberger M, Carpenter RHS, Kiernan MC, Hodges JR (2012) Saccadic abnormalities in frontotemporal dementia. Neurology 78:1816–1823
Burrell JR, Carpenter RHS, Hodges JR, Kiernan MC (2013) Early saccades in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 14:294–301
Bustamante J, Rimola A, Venture P-J, Navasa M, Cirera I, Reggiardo V, Rodes J (1999) Prognostic significance of hepatic encephalopathy in patients with cirrhosis. J Hepatol 30:890–895
Carpenter RHS (1981) Oculomotor procrastination. In: Fisher DF, Monty RA, Senders JW (eds) Eye movements: cognition and visual perception. Lawrence Erlbaum, Hillsdale, pp 237–246
Carpenter RHS (2000) The neural control of looking. Curr Biol 10:291–293
Carpenter RHS (2004a) Contrast, probability and saccadic latency: evidence for independence of detection and decision. Curr Biol 14:1576–1580
Carpenter RHS (2004b) The saccadic system: a neurological microcosm. Adv Clin Neurosci Rehabil 4:6–8
Carpenter RHS, Williams MLL (1995) Neural computation of log likelihood in the control of saccadic eye movements. Nature 377:59–62
Chandna A, Chandrasekharan DP, Ramesh AV, Carpenter RHS (2012) Altered interictal saccadic reaction time in migraine: a cross-sectional study. Cephalalgia 32:473–480
Dawson C, Murphy E, Maritz C, Chan H, Ellerton C, Carpenter RHS, Lachmann RH (2011) Dietary treatment of phenylketonuria: the effect of phenylalanine on reaction time. J Inherit Metab Dis 34:449–454
Ferenci P, Lockwood A, Mullen K, Weissenborn K, Blei AT (2002) Hepatic encephalopathy: definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna. Hepatology 35:716–721
Folstein MF, Marshal F, Folstein SE, McHugh PR (1975) Mini mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatry 12:189–198
Ghosh B, Rowe J, Carpenter R, Calder A, Peers P, Lawrence A, Hodges J (2010) Saccadic correlates of cognition in progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 81:E29
Groeneweg M, Quero JC, de Bruijn I, Hartmann JJC, Essink-Bot M, Hop WCJ, Schalm SW (1998) Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28:45–49
Groeneweg M, Moerland W, Quero JC, Hop WCJ, Krabbe PF, Schalm SW (2000) Screening of subclinical hepatic encephalopathy. J Hepatol 32(5):748–753
Häussinger D, Schliess F (2008) Pathogenetic mechanisms of hepatic encephalopathy. Gut 57:1156–1165
Hsu CY et al (2010) Comparison of the model for end-stage liver disease (MELD), MELD-Na and MELDNa for outcome prediction in patients with acute decompensated hepatitis. Dig Liver Dis 42:137–142
Joegbes EM, Heidemann M, Schimke N, Hecker H, Ennen JC, Weissenborn K (2003) Bradykinesia in minimal hepatic encephalopathy is due to disturbances in movement initiation. J Hepatol 38:273–280
Krismer F et al (2010) Saccadic latency in hepatic encephalopathy: a pilot study. Metab Brain Dis 25(3):285–295
Mattarozzi K, Stracciari A, Vignatelli L, d’Allesandro R, Morelli M, Guarino M (2004) Minimal hepatic encephalopathy: longitudinal effects of liver transplantation. Arch Neurol 61:242–247
Michell AW et al (2006) Saccadic latency distributions in Parkinson’s disease and the effects of L-dopa. Exp Brain Res 169:237–245
Montagnese S (2005) Disruption of smooth pursuit eye movements in cirrhosis: relationship to hepatic encephalopathy and its treatment. Hepatology 42:772–781
Nakahara H, Nakamura K, Hikosaka O (2006) Extended LATER model can account for trial-by-trial variability of both pre- and post-processes. Neural Netw 19:1027–1046
Noorani I, Carpenter RHS (2013) Antisaccades as decisions: LATER model predicts latency distributions and error responses. Eur J Neurosci 37:330–338
Ober JK, Przedpelska-Ober E, Gryncewicz W, Dylak J, Carpenter RHS, Ober JJ (2003) Hand-held system for ambulatory measurement of saccadic durations of neurological patients. In: Gajda J (ed) Modelling and measurement in medicine. Komitet Biocybernityki i Inzyneierii Biomedycznej PAN, Warsaw, pp 187–198
Ortiz M, Jacas C, Cordoba J (2005) Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 42:45–53
Perneczky R, Ghosh BC, Hughes L, Carpenter RH, Baker RA, Rowe JB (2011) Saccadic latency in Parkinson’s disease correlates with executive function and brain atrophy, but not motor severity. Neurobiol Dis 43:79–85
Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R (2007) Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45:549–559
Romero-Gomez M, Boza F, Garcia-Valdecasas MS, Garcia E, Aguilar-Reina J (2001) Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. J Gastroenterol 96:2718–2723
Romero-Gomez M, Grande L, Camacho I (2004) Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy. Hepatology 39:939–943
Romero-Gomez M et al (2007) Value of the critical flicker frequency in patients with minimal hepatic encephalopathy. Hepatology 45:879–885
Roos J, Lachmann R, Cox T, Carpenter R (2006) Saccadometry for estimating cerebral damage in storage diseases. Acta Paediatr 95:141
Rothstein JD et al (2005) b-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433:73–77
Schall JD (2005) Decision making. Curr Biol 15:R9–R11
Steinbrenner H, Alili L, Bilgic E, Sies H, Brenneisen P (2006) Involvement of selenoprotein P in protection of human astrocytes from oxidative damage. Free Radic Biol Med 40:1513–1523
Stewart CA, Smith GE (2007) Minimal hepatic encephalopathy. Nat Clin Pract Gastroenterol Hepatol 4:677–685
Stewart CA, Malinchoc M, Kim WR, Kamath PS (2007) Hepatic encephalopathy as a predictor of survival in patients with end stage liver disease. Liver Transpl 13:1366–1371
Temel Y, Visser-Vandewalle V, Carpenter RHS (2008) Saccadic latency during electrical stimulation of the human subthalamic nucleus. Curr Biol 18:R412–R414
Temel Y, Visser-Vandewalle V, Carpenter RHS (2009) Saccadometry: a novel clinical tool for quantification of the motor effects of subthalamic nucleus stimulation in Parkinson’s disease. Exp Neurol 216:481–489
Torlot FJ, McPhail MJW, Taylor-Robinson SD (2013) Meta-analysis: the diagnostic accuracy of critical flicker frequency in minimal hepatic encephalopathy. Aliment Pharmacol Ther 37:527–536
Watanabe A, Tuchida T, Yata Y, Kuwabara Y (1995) Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 10:239–248
Weissenborn K, Rückert N, Hecker H, Manns MP (1998) The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol 28:646–653
Weissenborn K, Ennen JC, Schomerus H, Rueckert N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:758–773
Yen CL, Liaw YF (1990) Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy. Hepatogastroenterology 37:332–334
Conflict of interest
None; financial support from the University of Cambridge
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cunniffe, N., Munby, H., Chan, S. et al. Using saccades to diagnose covert hepatic encephalopathy. Metab Brain Dis 30, 821–828 (2015). https://doi.org/10.1007/s11011-014-9647-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-014-9647-8